New research suggests that patients who stay on medications to treat opioid use disorder for one year or longer see an increased probability of survival. The new data could be a call for the broader industry to revisit the current minimum standard of treatments for OUD patients. The authors of the study, published in the […]
The start of the new year also marks just 12 months until 2027, when many provisions outlined in the One Big Beautiful Bill take effect — ushering in uncertainty for substance use disorder (SUD) providers around how Medicaid cuts, redeterminations and work requirements will affect operations and patient care. While there is palpable fear and […]
Pinnacle Treatment Centers has named a new CEO — its third in roughly two years. On Wednesday, the multi-state, multi-service addiction treatment provider said that it named Brian Lantier as CEO. Lantier comes from Traditions Health, a Franklin, Tennessee-based home health and hospice provider, where he first served as a board member and then CEO. […]
Consolidation and growth are happening in the office-based opioid treatment (OBOT) sector of the addiction treatment industry despite broader trends of market slowdown in the space. OBOT models originated as a way to make medication-assisted treatment (MAT) with buprenorphine, methadone and naltrexone more accessible by bringing it into a less stigmatized medical environment. These models […]
Substance use disorders cost the U.S. economy an estimated $93 billion in lost productivity in 2023—approximately $3,703 per adult with an SUD. That’s according to new research published in the American Journal of Preventive Medicine. The study’s authors broke down the total loss of productivity into four categories: inability to work accounted for $45.25 billion, […]
The arrival of 2026 will require substance use disorder (SUD) treatment providers to adjust the sails and tighten the ropes on areas providers do have control over during what could be a pivotal year for both policy and market activity. Unlike other areas of behavioral health in 2025, the SUD sector experienced an M&A market […]
This is an exclusive BHB+ story Clinician retention challenges in addiction treatment arise when daily duties diverge from the essential mission of providing care. The addiction treatment industry now has the opportunity to bring innovation to bear on perennial challenges in ways previously unimaginable. The advent and seemingly overnight proliferation of AI-backed software and the […]
President Donald Trump signed the SUPPORT for Patients and Communities Reauthorization Act of 2025 into law on Dec. 1, reauthorizing substance use disorder (SUD) prevention, treatment and recovery programs through fiscal year 2030. First passed in 2018, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act established these […]
This is an exclusive BHB+ story AI may be dominating the zeitgeist around changes in mental health care. Yet, novel virtual reality (VR) techniques are emerging with strong evidence-based outcomes, and the combination of AI and VR could advance treatments if reimbursement catches up. VR’s use cases range from exposure therapy treatments for mild phobias […]
Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved. A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
